Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$40.64$41.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.19B | 12.21B | 15.16B | 12.34B | 11.74B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.19B | 12.21B | 15.16B | 12.34B | 11.74B |
| Cost of Revenue | 2.18B | 2.66B | 2.13B | 2.21B | 2.80B |
| Gross Profit | 10.01B | 9.55B | 13.03B | 10.13B | 8.94B |
| SG&A Expenses | 2.50B | 2.54B | 2.07B | 2.67B | 2.80B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 275.31M | 36.42M | 16.60M | -12.63M | 18.33M |
| Total Operating Expenses | 7.31B | 7.02B | 5.83B | 6.84B | 8.03B |
| Operating Income | 4.88B | 5.20B | 9.34B | 5.49B | 3.71B |
| Income Before Tax | 3.30B | 4.18B | 9.74B | 5.33B | 4.00B |
| Income Tax Expenses | 722.77M | 916.02M | 2.13B | 1.14B | 863.28M |
| Earnings from Continuing Operations | 2.58B | 3.27B | 7.60B | 4.19B | 3.13B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.58B | 3.27B | 7.60B | 4.19B | 3.13B |
| EBIT | 4.88B | 5.20B | 9.34B | 5.49B | 3.71B |
| EBITDA | 5.44B | 5.76B | 9.89B | 5.71B | 4.30B |
| EPS Basic | 0.59 | 0.74 | 1.71 | 0.94 | 0.70 |
| Normalized Basic EPS | 0.66 | 0.73 | 1.37 | 0.82 | 0.56 |
| EPS Diluted | 0.58 | 0.74 | 1.71 | 0.94 | 0.70 |
| Normalized Diluted EPS | 0.66 | 0.73 | 1.37 | 0.82 | 0.56 |
| Average Basic Shares Outstanding | 4.41B | 4.43B | 4.44B | 4.44B | 4.45B |
| Average Diluted Shares Outstanding | 4.42B | 4.44B | 4.45B | 4.45B | 4.45B |
| Dividend Per Share | 0.00 | 0.58 | -- | 1.24 | 0.00 |
| Payout Ratio | 99.07% | 0.00% | 72.72% | 0.00% | 83.29% |